felin
infecti
periton
fip
one
import
infecti
diseas
cat
caus
felin
coronaviru
fcov
tissu
cultureadapt
type
fcov
show
reduc
fip
induct
experiment
infect
complic
understand
fip
pathogenesi
caus
type
fcov
previous
found
type
fcov
strain
effici
induc
fip
specificpathogenfre
cat
natur
infecti
rout
studi
employ
bacteri
artifici
chromosomebas
revers
genet
system
gain
insight
fip
caus
strain
success
gener
recombin
viru
cell
transfect
infecti
cdna
show
growth
kinet
similar
shown
parent
viru
next
construct
report
viru
carri
nanoluciferas
nluc
gene
measur
viral
replic
high
sensit
inhibitori
effect
differ
compound
could
measur
within
h
postinfect
furthermor
found
cell
deriv
canin
fibroblast
permit
fcov
replic
without
appar
cytopath
effect
thu
report
viru
use
uncov
infect
type
fcov
differ
cell
line
includ
caninederiv
cell
surprisingli
uncov
aberr
viral
rna
transcript
cell
overal
succeed
obtain
infecti
cdna
clone
deriv
type
fcov
retain
virul
recombin
fcov
power
tool
increas
understand
viral
life
cycl
pathogenesi
fipinduc
type
fcov
import
felin
coronaviru
fcov
one
signific
coronavirus
viru
induc
felin
infecti
periton
fip
lethal
diseas
cat
tissu
cultureadapt
type
fcov
often
lose
pathogen
complic
research
type
fcovinduc
felin
infecti
periton
fip
sinc
previous
found
type
fcov
strain
effici
induc
fip
specificpathogenfre
cat
establish
revers
genet
system
strain
obtain
recombin
virus
present
studi
use
report
viru
abl
examin
inhibitori
effect
compound
replic
cell
infect
caninederiv
cell
line
interestingli
one
canin
cell
line
permit
fcov
replic
low
effici
aberr
viral
gene
express
sequenc
fig
fulllength
infecti
cdna
clone
design
sequenc
analysi
show
possess
nucleotid
mutat
compar
refer
sequenc
tabl
mutat
synonym
nonsynonym
tabl
two
synonym
mutat
nt
nt
introduc
genet
marker
disrupt
ecori
site
confirm
viru
recoveri
cdna
clone
fig
see
also
tabl
viru
recoveri
transfect
produc
viru
cell
highli
suscept
fcov
infect
transfect
cell
low
level
cytopath
effect
cpe
observ
day
posttransfect
dpt
level
becam
higher
dpt
determin
rate
viru
recoveri
employ
revers
transcriptionpcr
rtpcr
isol
rna
parent
strain
confirm
genet
maker
analyz
ecori
digest
sanger
sequenc
fig
next
analyz
virolog
featur
viru
compar
growth
fulllength
sequenc
divid
fragment
fragment
sequenti
assembl
plasmid
backbon
asterisk
indic
site
genet
marker
b
nucleotid
sequenc
genom
nt
nt
ecori
restrict
site
underlin
rfcov
mutat
gaattc
gagttt
disrupt
ecori
site
use
genet
marker
mutat
nucleotid
shown
gray
box
white
letter
c
confirm
genet
marker
genom
ecori
treatment
rtpcr
product
parent
viru
amplifi
region
includ
genet
marker
treat
ecori
treat
sampl
subject
electrophoresi
confirm
disrupt
ecori
site
genom
sequenc
analysi
genet
marker
site
ecori
restrict
site
genet
marker
underlin
e
growth
kinet
parent
viru
cell
viru
inocul
onto
cell
moi
incub
h
viral
titer
cultur
supernat
measur
plaqu
assay
use
cell
lod
limit
detect
data
repres
mean
standard
deviat
sd
result
three
independ
experi
f
northern
blot
analysi
detect
viral
rna
cell
total
rna
cell
infect
parent
extract
subject
electrophoresi
transfer
viral
rna
hybrid
diglabel
rna
target
orf
grna
genom
rna
sgrna
subgenom
rna
kinet
parent
cell
inocul
virus
multipl
infect
moi
result
show
growth
kinet
similar
parent
fig
furthermor
compar
level
viral
rna
replic
parent
cell
northern
blot
analysi
fig
found
amount
genom
rna
grna
sg
mrna
cell
similar
seen
parent
cell
fig
take
result
togeth
abl
success
gener
infecti
cdna
clone
deriv
type
fcov
strain
use
bac
system
result
indic
recov
viru
possess
virolog
featur
ident
possess
parent
viru
fig
f
establish
report
bear
nluc
gene
virolog
recombin
virus
carri
report
gene
green
fluoresc
protein
gfp
red
fluoresc
protein
rfp
luciferas
present
mani
advantag
analyz
viral
characterist
screen
therapeut
compound
thu
attempt
construct
infecti
cdna
clone
type
fcov
strain
carri
nluc
gene
follow
protocol
teke
et
al
insert
nluc
gene
place
orf
gene
obtain
fig
nluc
gene
replac
region
begin
start
codon
orf
extend
nt
upstream
orf
stop
codon
retain
transcript
regulatori
sequenc
tr
gene
fig
examin
nluc
express
cell
infect
viru
inocul
cell
moi
infect
use
control
h
postinfect
hpi
found
nluc
activ
cellsbut
mockinfect
cellsincreas
timedepend
manner
fig
investig
viral
growth
cell
harvest
supernat
cell
hpi
determin
infecti
titer
supernat
plaqu
assay
level
product
infecti
viru
particl
cell
compar
cell
fig
shown
fig
c
increas
nluc
activ
significantli
correl
viral
replic
cell
data
indic
carri
nluc
report
gene
repres
power
tool
investig
type
fcov
replic
product
applic
report
viru
compound
screen
applic
report
viru
compound
screen
determin
sensit
viru
treatment
known
inhibitor
cov
replic
name
cyclosporin
csa
lopinavir
adsorpt
onto
cell
moi
infect
cell
treat
variou
concentr
csa
lopinavir
shown
fig
e
compound
inhibit
luciferas
activ
dosedepend
manner
furthermor
viral
rna
level
csatreat
lopinavirtr
cell
measur
realtim
rtpcr
fig
e
dosedepend
reduct
intracellular
viral
rna
level
found
compound
correl
luciferas
activ
suggest
sensit
detect
luciferas
express
level
cell
compar
viral
rna
express
level
next
determin
use
report
viru
screen
antivir
compound
util
commerci
avail
librari
proteas
inhibitor
cell
inocul
moi
concentr
proteas
inhibitor
csa
dimethyl
sulfoxid
dmso
use
posit
neg
control
respect
sideeffect
proteas
inhibitor
determin
bromid
mtt
assay
fig
fig
overal
result
support
idea
suitabl
compound
screen
identif
permiss
cell
line
type
fcov
vitro
propag
type
fcov
limit
cell
line
includ
cell
akd
cell
crfk
cell
type
fcov
show
cpe
cell
line
thu
difficult
investig
infect
type
fcov
cell
line
deriv
anim
dog
nevertheless
explor
novel
cell
line
propag
type
fcov
inocul
three
caninederiv
cell
line
canin
fibroblast
mdck
canin
kidney
epitheli
cell
canin
macrophag
viru
moi
investig
infect
measur
nluc
activ
although
cpe
observ
cell
nluc
activ
significantli
high
hpi
increas
timedepend
manner
fig
c
hand
mdck
cell
exhibit
detect
nluc
activ
fig
determin
viral
rna
replic
cell
mdck
cell
infect
viru
moi
follow
realtim
rtpcr
analysi
rna
extract
hpi
although
amount
viral
rna
cell
lower
cell
amount
viral
rna
cell
mdck
cell
still
significantli
high
hpi
fig
result
indic
cell
permit
replic
type
fcov
viru
next
determin
level
product
infecti
viru
particl
cell
collect
cultur
supernat
hpi
measur
viral
titer
plaqu
assay
cell
fig
supernat
infecti
titer
cell
reach
pfuml
hpi
amount
viral
rna
determin
realtim
rtpcr
increas
timedepend
manner
cell
fig
e
shown
fig
cell
support
viru
replic
product
infecti
virus
lower
seen
cell
meanwhil
infecti
virus
produc
infect
mdck
cell
fig
result
indic
cell
produc
progeni
virusesalbeit
low
efficiencywhil
mdck
cell
permiss
cell
line
type
fcov
determin
low
level
product
progeni
viru
cell
examin
propag
viru
moi
cell
indirect
immunofluoresc
assay
ifa
use
confoc
microscopi
analysi
use
antifcov
n
monoclon
antibodi
mab
n
protein
express
cell
observ
ifa
cell
exhibit
small
foci
hpi
compar
exhibit
cell
fig
therefor
infecti
particl
found
gener
cell
low
effici
infect
expans
progeni
particl
neighbor
cell
also
examin
n
protein
express
level
use
immunoblot
expect
n
protein
express
level
virusinfect
cell
significantli
low
fig
although
level
product
progeni
viru
n
protein
low
result
suggest
caninederiv
cell
repres
permiss
cell
line
type
fcov
infect
without
cytotox
effect
fig
unlik
result
seen
cell
neither
viral
rna
replic
progeni
viru
product
observ
mdck
cell
infect
viru
result
led
us
specul
entri
receptor
type
fcov
perhap
express
mdck
cell
viral
rna
replic
type
fcov
permit
cell
line
unfortun
type
fcov
receptor
remain
unknown
thu
examin
viral
replic
level
cell
transfect
neg
control
gener
mutat
activ
site
viral
rnadepend
rna
polymeras
rdrp
sdd
saa
fig
confirm
viru
rescu
occur
cell
transfect
disrupt
rdrp
activ
data
shown
transfect
mdck
cell
fig
express
level
n
protein
infect
cell
significantli
low
thu
determin
express
level
sg
n
mrna
sg
total
rna
extract
virusinfect
mockinfect
cell
hpi
subject
northern
blot
analysi
specif
type
fcov
untransl
region
probe
fig
found
viral
rna
includ
grna
sg
detect
cell
infect
viru
fig
howev
express
level
grna
sg
significantli
lower
infect
cell
infect
cell
fig
next
determin
specif
rna
signal
infect
cell
gener
set
specif
digoxigenin
dig
label
rna
probe
n
gene
fig
shown
fig
identifi
seven
specif
viral
mrna
grna
sg
use
combin
nspecif
rna
probe
infect
cell
unexpect
rna
signal
observ
sg
sg
fig
result
indic
two
rna
detect
cell
infect
sg
sg
examin
express
level
viral
sg
mrna
cell
infect
parent
strain
type
fcov
strain
yayoi
use
northern
blot
analysi
specif
rna
probe
although
grna
sg
detect
cell
infect
strain
yayoi
strain
two
specif
mrnassg
sg
observ
cell
infect
yayoi
fig
result
suggest
decreas
synthesi
viral
mrna
specif
infecti
clone
although
express
level
sg
sg
cell
infect
low
fig
ratio
sg
express
sg
express
infect
cell
differ
infect
cell
level
sg
infect
cell
determin
basi
level
sg
lower
infect
cell
fig
infecti
cdna
clone
virul
type
fcov
journal
virolog
use
smaller
amount
total
rna
extract
infect
cell
northern
blot
analysi
adjust
express
level
sg
infect
cell
result
express
level
sg
cell
ident
cell
wherea
express
level
sg
cell
lower
cell
fig
find
indic
aberr
express
viral
rna
occur
infect
cell
epidemiolog
research
conduct
type
fcov
led
propos
presenc
virul
factor
viral
genom
howev
experiment
confirm
presenc
virul
factor
difficult
vivo
due
lack
feasibl
fip
cat
model
type
fcov
recent
found
type
fcov
strain
abil
induc
fip
spf
cat
thu
present
studi
construct
infecti
cdna
clone
deriv
virulenceretain
type
fcov
strain
util
bac
system
result
success
rescu
recombin
type
fcov
transfect
bac
cdna
clone
cell
recov
show
growth
kinet
similar
parent
viru
fig
addit
gener
recombin
type
fcov
carri
nluc
report
gene
appli
report
viru
drug
screen
fig
sever
host
proteas
furin
cathepsin
requir
entri
step
cov
mediat
cleav
spike
protein
cell
surfac
endosom
consist
find
identifi
nafamostat
mesyl
compound
fcov
inhibitor
show
cytotox
effect
suggest
fcov
util
host
proteas
entri
anoth
compound
lopinavir
inhibitor
human
immunodefici
viru
type
proteas
use
aid
treatment
coronaviru
infect
lopinavir
inhibit
merscov
sever
acut
respiratori
syndrom
coronaviru
sarscov
human
cov
hcov
infect
inhibit
cov
proteas
belong
genu
fcovalphacoronaviru
unsurprisingli
identifi
lopinavir
compound
fcov
inhibitor
exhibit
cytotox
result
suggest
nafamostat
lopinavir
potenti
therapeut
agent
fcov
infect
specif
chemic
compound
activ
type
fcov
appli
two
differ
strategi
fip
name
cure
prevent
sever
studi
attempt
develop
cur
therapeut
agent
fip
although
compound
suppress
fcov
replic
vitro
compound
fail
suppress
fip
vivo
differ
vitro
vivo
activ
compound
remain
controversi
highli
complic
patholog
mechan
fip
includ
compon
antibodydepend
enhanc
infect
ade
type
iii
hypersensit
make
develop
effici
cur
therapeut
fip
difficult
hand
emerg
mechan
fipv
best
explain
intern
mutat
theori
type
fcov
potenti
becom
type
fipv
acquir
mutat
viral
genom
replic
kitten
therefor
control
viral
load
type
fcov
kitten
import
prevent
onset
fip
diseas
chemic
compound
suppress
viral
load
type
fcov
kitten
probabl
diseas
onset
reduc
thu
use
therapeut
type
fcov
would
effici
method
control
fip
regard
report
viru
repres
power
tool
find
compound
use
cure
andor
prevent
fip
viru
util
highthroughput
screen
sever
report
address
possibl
virus
among
member
type
ii
fcov
type
canin
cov
ccov
type
iib
ccov
emerg
chimer
virus
via
recombin
event
felin
aminopeptidas
n
apn
work
viral
receptor
type
ii
ccov
porcin
transmiss
gastroenter
viru
tgev
suggest
cat
especi
kitten
play
import
role
produc
new
chimer
virus
howev
possibl
recombin
anim
dog
wellstudi
furthermor
best
knowledg
report
shown
type
fcov
induct
appar
cpe
cell
cultur
except
cell
inde
strain
type
fcov
exhibit
cpe
caninederiv
cell
fig
howev
level
luciferas
activ
cell
infect
viru
significantli
increas
without
concomit
cpe
fig
c
although
progeni
viru
product
level
low
cell
permit
type
fcov
replic
fig
reason
investig
type
fcov
infect
cell
line
reli
sole
cpebas
assay
furthermor
find
indic
event
recombin
type
fcov
ccov
may
occur
dog
specif
type
fcov
may
transmit
cat
dog
new
cov
may
emerg
dog
recombin
event
fact
ccov
replic
cell
like
positivestrand
virus
cov
requir
host
factor
replic
infect
cell
unlik
cell
mdck
cell
permit
viral
replic
type
fcov
fig
thu
hypothes
essenti
host
factor
exist
caninederiv
cell
mdck
cell
futur
research
elucid
host
factor
support
replic
type
fcov
cell
factor
would
attract
target
develop
therapeut
type
fcov
recent
mani
research
focus
bat
major
reservoir
novel
virus
sever
novel
virus
identifi
andor
isol
bat
relat
humanpathogen
virus
sarscov
merscov
howev
anim
speci
also
potenti
novel
viru
reservoir
exampl
lau
et
al
report
deltacoronaviru
porcin
cov
porcov
transmit
bird
pig
addit
hcov
known
origin
bovin
cov
therefor
bat
also
anim
speci
investig
potenti
reservoir
sourc
emerg
virus
inde
found
caninederiv
cell
line
permit
replic
type
fcov
fig
although
host
receptor
type
fcov
remain
unclear
use
report
viru
fcov
infect
may
provid
insight
viral
host
jump
emerg
novel
virus
gener
express
level
sg
highest
among
viral
mrna
covinfect
cell
sg
express
level
cell
lower
cell
express
ratio
sg
sg
infect
cell
differ
infect
cell
fig
fact
express
level
sg
g
total
rna
extract
infect
cell
similar
express
level
g
total
rna
extract
cell
fig
contrast
express
level
sg
cell
lower
cell
fig
suggest
synthesi
sg
mrna
impair
cell
realtim
rtpcr
method
amplifi
viral
rna
present
viral
rna
therefor
increas
viral
rna
cell
fig
possibl
caus
synthesi
sg
fig
knowledg
report
aberr
rna
transcript
cov
infect
cell
cell
sever
host
protein
member
heterogen
nuclear
ribonucleoprotein
hnrnp
famili
dead
box
rna
helicas
famili
interact
tr
cov
rna
regul
transcriptionrepl
thu
data
indic
host
factor
present
cell
cell
regul
viral
rna
transcript
basi
aberr
express
viral
mrna
seen
virusinfect
cell
studi
requir
uncov
cov
rna
transcript
mechan
cell
conclus
gener
recombin
type
fcov
strain
use
bacbas
revers
genet
system
recombin
viru
potenti
use
expand
research
type
fcovinduc
fip
furthermor
infect
cell
viru
reveal
unusu
viral
mrna
express
pattern
may
provid
novel
insight
mechan
cov
transcript
although
studi
requir
test
whether
recombin
viru
induc
fip
vivo
establish
type
fcov
clone
potenti
power
tool
understand
fip
pathogenesi
exampl
gene
candid
fcov
pathogenesi
chimer
gene
viru
correspond
recombin
viru
may
provid
novel
insight
type
fcov
pathogenesi
addit
group
previous
establish
type
fcov
revers
genet
use
black
strain
type
field
viru
thu
exploit
multipl
approach
synergist
understand
fip
catderiv
cell
caninederiv
cell
line
mdck
grown
dulbecco
modifi
eagl
medium
dmem
nacalai
tesqu
kyoto
japan
supplement
mdck
cell
cell
heatinactiv
fetal
bovin
serum
fb
uml
penicillin
gml
streptomycin
nacalai
tesqu
cell
maintain
humidifi
co
incub
type
fcov
strain
yayoi
use
studi
propag
cell
describ
previous
bac
construct
bac
dna
sarscovrep
kindli
provid
lui
enjuan
spanish
nation
center
biotechnolog
cnbcsic
madrid
spain
use
backbon
bac
sequenc
gener
infecti
cdna
carri
fulllength
type
fcov
strain
sequenc
fulllength
genom
sequenc
divid
fragment
assembl
plasmid
sequenti
order
fig
fragment
correspond
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
respect
redet
recombin
employ
fragment
integr
redet
recombin
system
counterselect
bac
modif
kit
gene
bridg
heidelberg
germani
accord
manufactur
instruct
cdna
correspond
end
genom
rna
nt
nt
adenin
pa
partial
hdv
ribozym
rz
sequenc
gener
chemic
synthesi
eurofin
brussel
belgium
cdna
use
pcr
templat
synthes
fig
synthes
fragment
rtpcr
carri
use
genom
rna
strain
describ
rna
extract
rtpcr
see
amplif
revers
primer
design
disrupt
ecori
site
nt
nt
fig
cdna
clone
carri
fulllength
sequenc
design
sequenc
analysi
fullgenom
sequenc
carri
eurofin
construct
report
replac
orf
gene
nluc
promega
fitchburg
wi
use
recombin
method
describ
fig
design
infecti
cdna
clone
recombin
method
appli
construct
possess
amino
acid
substitut
sdd
saa
activ
site
rdrp
fig
rna
extract
rtpcr
viral
rna
viral
stock
type
fcov
strain
strain
extract
use
purelink
rna
minikit
thermo
fisher
scientif
waltham
accord
manufactur
instruct
rna
subject
revers
transcript
use
superscript
iii
firststrand
synthesi
system
rtpcr
invitrogen
waltham
random
hexam
accord
manufactur
instruct
pcr
carri
use
primestar
gxl
dna
polymeras
takara
shiga
japan
cdna
use
pcr
templat
synthes
recombin
templat
describ
cdna
use
genet
marker
confirm
total
rna
virusinfect
mockinfect
cell
cell
isol
subject
revers
transcript
describ
plasmid
construct
obtain
diglabel
riboprob
detect
fcov
rna
via
northern
blot
analysi
construct
plasmid
nucleotid
sequenc
nt
nt
genom
clone
plasmid
ligat
use
hindiii
ecori
restrict
site
dna
ligat
kit
mighti
mix
takara
furthermor
construct
escherichia
coli
express
plasmid
produc
glutathion
stransferas
gst
fuse
partial
n
protein
nucleotid
sequenc
nt
nt
encod
amino
acid
residu
insert
ligat
use
bamhi
xhoi
restrict
site
dna
ligat
kit
mighti
mix
rescu
suscept
cell
cell
seed
onto
plate
violamo
misumi
schaumberg
il
cellswel
incub
overnight
cell
transfect
use
g
cdna
clone
xtremegen
dna
transfect
reagent
roch
basel
switzerland
accord
manufactur
instruct
day
cultur
cpe
observ
cultur
supernat
harvest
supernat
store
passag
virus
virus
passag
twice
fresh
cell
dish
violamo
virus
use
conduct
experi
genet
marker
confirm
determin
genet
marker
cdna
use
templat
pcr
use
primer
pair
primestar
gxl
dna
polymeras
pcr
product
purifi
use
highpur
pcr
purif
kit
roch
dna
sampl
treat
ecori
overnight
treat
sampl
subject
electrophoresi
cleavag
verifi
purifi
dna
sampl
also
use
sequenc
analysi
confirm
genet
marker
sequenc
analys
carri
eurofin
use
primer
mdck
cell
seed
onto
plate
cellswel
respect
cultur
overnight
virus
use
inocul
cell
line
moi
adsorpt
h
cell
wash
twice
dmem
fresh
dmem
contain
fb
ad
infect
cell
cultur
h
cultur
supernat
collect
store
use
titrat
assay
next
infect
cell
collect
wash
use
phosphatebuff
salin
pb
cell
pellet
divid
two
aliquot
realtim
rtpcr
western
blot
analysi
measur
viral
titer
plaqu
assay
cell
seed
onto
plate
cellswel
cultur
overnight
sampl
dilut
serial
dilut
dilut
use
dmem
dilut
virus
l
ad
cell
mixtur
incub
h
adsorpt
adsorpt
supernat
remov
cell
wash
twice
use
dmem
next
mixtur
agaros
seaplaqu
gtg
agaros
lonza
basel
switzerland
dmem
contain
fb
overlaid
infect
cell
cell
incub
cpe
observ
final
infect
cell
fix
phosphatebuff
formalin
nacalai
tesqu
stain
crystal
violet
number
plaqu
determin
viral
titer
calcul
number
pfu
per
millilit
northern
blot
analysi
rna
cell
use
northern
blot
analysi
describ
elsewher
rna
sampl
dilut
g
l
use
ultrapur
distil
water
dw
invitrogen
mix
l
load
dye
new
england
biolab
ipswich
heat
perform
min
rna
sampl
subject
electrophoresi
denatur
agaros
gel
transfer
onto
posit
charg
nylon
membran
roch
northern
blot
analysi
perform
use
dig
wash
block
buffer
set
dig
luminesc
detect
kit
roch
diglabel
riboprob
detect
viral
rna
gener
use
dig
rna
label
kit
roch
describ
previous
measur
nluc
activ
cell
cellswel
mdck
cell
cellswel
seed
onto
plate
violamo
cultur
overnight
wash
inocul
moi
adsorpt
cell
wash
twice
use
dmem
fresh
dmem
contain
fb
ad
cell
incub
h
cultur
supernat
remov
cell
lyse
use
passiv
buffer
promega
luciferas
activ
level
measur
use
nanoglo
luciferas
assay
system
promega
powerscan
ht
luminomet
ds
pharma
biomed
osaka
japan
experi
carri
triplic
measur
inhibitori
effect
type
fcov
replic
cell
seed
onto
plate
cellswel
cultur
overnight
wash
cell
perform
l
use
inocul
moi
adsorpt
h
infect
cell
wash
twice
dmem
fresh
dmem
supplement
fb
differ
concentr
csa
sigmaaldrich
st
loui
mo
lopinavir
sigmaaldrich
ad
use
serial
dilut
perform
dmso
csa
dilut
lopinavir
dmso
also
use
control
incub
h
cultur
supernat
remov
cell
lyse
passiv
buffer
nluc
activ
measur
describ
compound
screen
use
proteas
inhibitor
librari
use
chemic
librari
compound
proteas
inhibitor
librari
targetmol
compound
screen
tabl
cell
seed
onto
plate
violamo
cellswel
cultur
overnight
mixtur
contain
moi
concentr
compound
librari
prepar
dmem
ad
cultur
cell
csa
dmso
use
posit
neg
control
respect
incub
h
cultur
supernat
remov
cell
lyse
passiv
buffer
nluc
activ
measur
describ
mtt
assay
cell
seed
onto
plate
cellswel
cultur
overnight
compound
dmem
proteas
inhibitor
librari
ad
cultur
cell
incub
h
mtt
assay
carri
use
mtt
cell
count
kit
nacalai
tesqu
accord
manufactur
instruct
absorb
nm
measur
powerscan
ht
luminomet
realtim
rtpcr
cell
pellet
infect
mdck
cell
lyse
total
rna
extract
use
purelink
rna
minikit
rna
use
realtim
rtpcr
thunderbird
probe
onestep
quantit
pcr
qpcr
mix
toyobo
osaka
japan
run
stepon
realtim
pcr
system
appli
biosystem
waltham
quantif
fcov
rna
use
target
primer
nt
nt
well
specif
probe
nt
label
fam
quantif
gapdh
dehydrogenas
mrna
use
primer
famlabel
use
probe
cycl
condit
min
follow
cycl
continu
next
page
construct
monoclon
antibodi
n
protein
type
fcov
gstfuse
partial
n
protein
express
escherichia
coli
carri
purifi
use
glutathion
sepharos
bead
ge
healthcar
chicago
il
purifi
protein
use
antigen
immun
balbc
mice
method
monoclon
antibodi
mab
establish
describ
previous
screen
hybridoma
perform
enzymelink
immunosorb
assay
elisa
use
purifi
gst
protein
elisa
carri
describ
previous
experi
yield
clone
design
produc
mab
type
fcov
n
protein
western
blot
analysi
infect
mdck
cell
lyse
lysi
buffer
mm
trishcl
ph
mm
nacl
triton
centrifug
g
min
supernat
collect
mix
sampl
buffer
trishcl
ph
sodium
dodecyl
sulfat
sd
glycerol
bromophenol
blue
next
boil
sampl
subject
electrophoresi
sdspolyacrylamid
gel
electrophoresi
sdspage
transfer
onto
polyvinyliden
difluorid
pvdf
membran
merck
millipor
billerica
membran
block
skim
milkpb
contain
tween
pbst
nacalai
tesqu
primari
antibodi
mous
antifcovn
monoclon
antibodi
mous
antibodi
sigmaaldrich
goat
antimous
igg
horseradish
peroxidas
hrp
sigmaaldrich
use
secondari
antibodi
chemilumi
one
ultra
nacalai
tesqu
use
visual
ifa
cell
seed
onto
glassbottom
dish
matsunami
glass
osaka
japan
cellswel
respect
incub
overnight
cell
inocul
moi
follow
adsorpt
h
supernat
remov
fresh
dmem
contain
fb
ad
infect
cell
cultur
h
fix
paraformaldehydepb
wash
perform
pb
cell
permeabil
min
room
temperatur
pb
contain
triton
cell
incub
mous
antifcovn
monoclon
antibodi
overnight
wash
three
time
pb
incub
antimous
igg
sigmaaldrich
h
room
temperatur
final
cell
wash
three
time
pb
fluoroshield
dapi
immunobiosci
mukilteo
wa
use
mount
medium
counterstain
nuclei
dapi
cell
observ
fluoview
laser
scan
confoc
microscop
olympu
tokyo
japan
transfect
mdck
cell
pbacfcovnluc
mdck
cell
seed
onto
plate
cellswel
cultur
overnight
cell
transfect
g
pbacfcovnluc
g
use
lipofectamin
thermo
fisher
scientif
accord
manufactur
instruct
pbacfcovnlucpoldead
use
control
transfect
cell
incub
h
supernat
remov
fresh
dmem
contain
fb
ad
incub
perform
addit
h
ie
h
transfect
cultur
supernat
remov
cell
lyse
passiv
buffer
level
nluc
firefli
luciferas
activ
measur
describ
luciferas
assay
system
promega
respect
nluc
activ
normal
firefli
luciferas
activ
virolog
test
fig
experi
scale
plate
plate
